MENU

Movement Disorders

About this condition
Patient & Caregiver Tools
Articles
Movement Disorders Moment: Atypical Parkinsonisms image

Columns

Movement Disorders Moment: Atypical Parkinsonisms

Pearls from the September 2019 International Congress of Parkinson’s Disease and Movement Disorders

Jill M. Giordano Farmer, DO

Gene Therapy for Parkinson’s Disease image

Cover Focus

Gene Therapy for Parkinson’s Disease

Gene therapies can be safely delivered; the questions of when, where, and why to use them remains.

Frederick Hitti, MD, PhD

Hyperkinetic Movement Disorders image

Cover Focus

Antisense Oligonucleotide Therapies

Antisense oligonucleotides are a promising new therapeutic class being studied for the treatment of movement disorders.

Amber D. Van Laar, MD; and Victor S. Van Laar, PhD

September 2019 teaser

Cover Focus

Hyperkinetic Movement Disorders

New formulations for motor symptoms and new treatments for nonmotor symptoms provide more options.

Zehra Farzal, MD; Guillaume Lamotte MD, MSc; and Laxman B. Bahroo, DO

Parkinson’s Disease Treatment Update image

Cover Focus

Parkinson’s Disease Treatment Update

New formulations for motor symptoms and new treatments for nonmotor symptoms provide more options.

Zehra Farzal, MD; Guillaume Lamotte MD, MSc; and Laxman B. Bahroo, DO

Imaging in Parkinson’s Disease image

Cover Focus

Imaging in Parkinson’s Disease

Imaging studies can differentiate Parkinson’s from other causes of parkinsonism.

Catherine L. Gallagher, MD

September 2019 teaser

Chief Medical Editor's Page

Movement Disorders Aims for Precision

With the refinement of treatments and imaging and new technologies, the field of movement disorders speeds toward precision medicine.

Stephen M. Gollomp, MD

About the Cover Artist: Patrick J. Murphy image

About The Cover Artist

About the Cover Artist: Patrick J. Murphy

Patrick J. Murphy considered his Parkinson’s disease diagnosis a wake-up call and permission slip to pursue a lifelong dream in fine art.

Movement Disorders Moment: Neurodegenerative
Spinocerebellar Ataxia image

Columns

Movement Disorders Moment: Neurodegenerative Spinocerebellar Ataxia

Can we do better than localizing the lesion?

Liana Rosenthal, MD, PhD

Case Report: Hemiparkinsonism in a Patient With Multiple Sclerosis image

Case Report

Case Report: Hemiparkinsonism in a Patient With Multiple Sclerosis

In this case, there was a causal relationship between comorbid diseases.

Andrea P. Lee, MD; Giulietta M. Riboldi, MD; Ilya Kister, MD; Jonathan E. Howard, MD; and Ritesh A. Ramdhani, MD

slp-neurodeg.jpg

Sleep & Neurodegenerative Disease

Sleep problems are common and treatable in neurodegenerative disorders, and may also be a treatable risk factor and early biomarker.

Raman K. Malhotra, MD

PN Teaser 2019-01.png

Spotlight Topic: Neuropsychiatry

Cognitive Complaints and Neuropsychologic Testing

When should neuropsychologic tests be ordered and what questions should testing answer?

Nabil Ali, MD; Laura M. Clark, PhD, ABPP; and Kendra Corning, PsyD, HSPP

PN Teaser 2018-12.png

Cover Focus: Technology & Wellness

Treating Stress to Improve Neurologic Outcomes

Research on the interaction between hormones and seizures supports the importance of helping patients manage stress.

Riley Bove, MD, MMSc; and Graham R. Huesmann, MD, PhD

PN Teaser 2018-12.png

Healthy Cognitive Aging

There are evidence-based tools for staying sharp throughout the lifespan.

Brian K. Lebowitz, PhD, ABPP-CN; Elizabeth Londen, PhD; and Thomas Preston, PhD, ABPP-CN

PN Teaser 2018-12.png

Moving the Mouse With the Mind

Braingate technology allows patients with tetrapalegia to move a computer cursor by thinking about it.

Leigh R. Hochberg, MD, PhD

PN Teaser 2018-12.png

Guest Medical Editor's Page

Wellness and Neurology

There is clear evidence for promoting wellness practices to all patients with neurologic disorders.

Patricia K. Coyle, MD, FAAN, FANA

PN Teaser 2018-10.png

Movement Disorders Moment: Shining a Light on the Off Periods of Parkinson's Disease

New formulations for rescue from the off period are coming.

Jill M. Giordano Farmer, DO; and Jeffrey Lahrmann, MD

PN Teaser 2018-09.png

Seeking Breakthroughs: The Physician Perspective

A roundtable discussion with Claudia A. Chiriboga, MD, MPH; Jeffrey L. Cummings, MD, ScD; and Nir Lipsman, MD, PhD

Claudia A. Chiriboga, MD, MPH; Jeffrey L. Cummings, MD, ScD; and Nir Lipsman, MD, PhD

PN Teaser 2018-09.png

Seeking Breakthroughs: The Startup Perspective

A roundtable discussion with Chase Spurlock, PhD, IQuity; Michal Izrael, PhD, Kadimastem Ltd; Kevin Hrusovsky, Quanterix; and J. Michael Ryan, MD, Rodin Therapeutics

PN Teaser 2018-09.png

Anti-Alpha-Synuclein Therapies in Parkinson's Disease

Could therapies developed to stop cancers be the next breakthrough for neurodegenerative disorders?

Laxman B. Bahroo, DO; Mazen T. Elkurd, DO; Charbel E.-H. Moussa, MD, PhD; Fernando L. Pagan, MD; and Yasar Torres-Yaghi, MD

This Month's Issue
Challenge Case Report: Aseptic Meningitis Worsening With Treatment

David Horvat, MD; Jack Lovell, DO; and Glen Cook Jr, MD

The Importance of Neuroimaging

Anand Karthik Sarma, MD

RAPID Automated CT Perfusion in Clinical Practice

Brady Laughlin, DO; Alex Chan, DO; Waimei Amy Tai, MD; and Parham Moftakhar, MD